{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:45:24Z","timestamp":1792154724790,"version":"4.4.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0070701","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T02:42:52Z","timestamp":1376534572000},"page":"e70701","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Selective \u03ba Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and Transporters"],"prefix":"10.1371","volume":"8","author":[{"given":"Thomas A.","family":"Munro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee","family":"Van't Veer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Ivy","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"B\u00e9guin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Carlezon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola A.","family":"Colabufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314","author":"AT Knoll","year":"2010","journal-title":"Brain Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pharmthera.2009.05.008","article-title":"Kappa-opioid ligands in the study and treatment of mood disorders","volume":"123","author":"WA Carlezon Jr","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"B\u00e9guin C, Cohen BM (2009) Medicinal Chemistry of Kappa Opioid Receptor Antagonists. In: Dean RL, Bilsky EJ, Negus SS, editors. Opiate Receptors and Antagonists: from Bench to Clinic. New York: Humana Press. pp. 99\u2013118. doi:10.1007\/978-1-59745-197-0_6","DOI":"10.1007\/978-1-59745-197-0_6"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"E704","DOI":"10.1208\/aapsj070371","article-title":"Kappa opioid antagonists: Past successes and future prospects","volume":"7","author":"M Metcalf","year":"2005","journal-title":"AAPS J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"29803","DOI":"10.1074\/jbc.M705540200","article-title":"Long-Acting \u03ba Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating c-Jun N-Terminal Kinase","volume":"282","author":"MR Bruchas","year":"2007","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.111.074195","article-title":"Duration of Action of a Broad Range of Selective Kappa Opioid Receptor Antagonists is Positively Correlated with c-Jun N-Terminal Kinase-1 Activation","volume":"80","author":"EJ Melief","year":"2011","journal-title":"Mol Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2210-12-5","article-title":"Long-acting \u03ba opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity","volume":"12","author":"TA Munro","year":"2012","journal-title":"BMC Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(01)00941-4","article-title":"Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice","volume":"418","author":"J Kamei","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"ref9","unstructured":"Inan S (2010) Pharmacological and neuroanatomical analysis of GNTI-induced repetitive behavior in mice [Ph.D. thesis Thesis]. Philadelphia, PA: Temple University. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/digital.library.temple.edu\/cdm\/ref\/collection\/p245801coll10\/id\/75332\" xlink:type=\"simple\">http:\/\/digital.library.temple.edu\/cdm\/ref\/collection\/p245801coll10\/id\/75332<\/ext-link> archived at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.webcitation.org\/66yCyVaZH\" xlink:type=\"simple\">http:\/\/www.webcitation.org\/66yCyVaZH<\/ext-link>. Accessed 2013 July 2."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1369-1600.2012.00455.x","article-title":"The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety","volume":"17","author":"JR Schank","year":"2012","journal-title":"Addict Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.biopsych.2011.05.021","article-title":"Repeated Exposure to the \u03ba-Opioid Receptor Agonist Salvinorin A Modulates Extracellular Signal-Regulated Kinase and Reward Sensitivity","volume":"70","author":"DN Potter","year":"2011","journal-title":"Biol Psychiatry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1745-7254.2006.00448.x","article-title":"Effect of GNTI, a kappa opioid receptor antagonist, on MK-801-induced hyperlocomotion and stereotypy in mice","volume":"27","author":"CT Qi","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0031-9384(96)00103-5","article-title":"Reductions in locomotor activity following central opioid receptor subtype antagonists in rats","volume":"60","author":"L Leventhal","year":"1996","journal-title":"Physiol Behav"},{"key":"ref14","first-page":"1237","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"P Horan","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"ref15","first-page":"30","article-title":"Nor-binaltorphimine: a potent and selective \u03ba-opioid receptor antagonist with long-lasting activity in vivo","volume":"316","author":"T Endoh","year":"1992","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00213-002-1038-x","article-title":"Kappa opioid antagonist effects of the novel kappa antagonist 5\u2032-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys","volume":"163","author":"S Negus","year":"2002","journal-title":"Psychopharmacology"},{"key":"ref17","first-page":"16","article-title":"Preclinical toxicity studies of naltrexone","volume":"9","author":"MC Braude","year":"1976","journal-title":"NIDA Res Monogr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0269881112464828","article-title":"In vivo and in vitro characterization of naltrindole-derived ligands at the kappa-opioid receptor","volume":"27","author":"JJ Casal-Dominguez","year":"2013","journal-title":"J Psychopharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0006-8993(90)90112-O","article-title":"Nor-binaltorphimine decreases deprivation and opioid-induced feeding","volume":"534","author":"AS Levine","year":"1990","journal-title":"Brain Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-8993(01)02624-5","article-title":"The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats","volume":"909","author":"DC Jewett","year":"2001","journal-title":"Brain Res"},{"key":"ref21","unstructured":"Need A (2008) Development and characterization of a methodology for the simultaneous and individual determination of in vivo receptor occupancy at mu, delta, and kappa opioid receptors, and examination of the effects of opioid antagonist occupancy on feeding behavior in the rat [Ph.D. Thesis]. Indianapolis, IN: Indiana University. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/gradworks.umi.com\/33\/04\/3304655.html\" xlink:type=\"simple\">http:\/\/gradworks.umi.com\/33\/04\/3304655.html<\/ext-link>. Accessed 2013 July 2."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Cowan A, Inan S (2009) Kappa-Opioid Antagonists as Pruritogenic Agents. In: Dean RL, Bilsky EJ, Negus SS, editors. Opiate Receptors and Antagonists: from Bench to Clinic. New York: Humana Press. pp. 541\u2013549. doi:10.1007\/978-1-59745-197-0_28","DOI":"10.1007\/978-1-59745-197-0_28"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2009.06.026","article-title":"Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5\u2032-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence","volume":"616","author":"S Inan","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2009.06.016","article-title":"Nalfurafine prevents 5\u2032-guanidinonaltrindole- and compound 48\/80-induced spinal c-fos expression and attenuates 5\u2032-guanidinonaltrindole-elicited scratching behavior in mice","volume":"163","author":"S Inan","year":"2009","journal-title":"Neuroscience"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.peptides.2010.11.022","article-title":"Investigation of gastrin-releasing peptide as a mediator for 5\u2032-guanidinonaltrindole-induced compulsive scratching in mice","volume":"32","author":"S Inan","year":"2011","journal-title":"Peptides"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-2999(93)90463-R","article-title":"Norbinaltorphimine protection against N-methyl-<sc>d<\/sc>-aspartic acid-induced convulsions and mortality","volume":"231","author":"VK Shukla","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2006.12.041","article-title":"Dynorphin displaces binding at the glycine site of the NMDA receptor in the rat striatum","volume":"415","author":"P Voorn","year":"2007","journal-title":"Neurosci Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1210\/endo.141.7.7587","article-title":"A subset of kappa opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain","volume":"141","author":"SJ Evans","year":"2000","journal-title":"Endocrinology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"32016","DOI":"10.1074\/jbc.271.50.32016","article-title":"Moving from the orphanin FQ receptor to an opioid receptor using four point mutations","volume":"271","author":"F Meng","year":"1996","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1248\/bpb.24.902","article-title":"Characterization of Specific [<sup>3<\/sup>H]Nociceptin Binding in Rat Brain and Spinal Cord","volume":"24","author":"T Kusaka","year":"2001","journal-title":"Biol Pharm Bull"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"J Besnard","year":"2012","journal-title":"Nature"},{"key":"ref32","first-page":"713","article-title":"Facilitatory Interplay in \u03b1<sub>1A<\/sub> and \u03b2<sub>2<\/sub> Adrenoceptor Function Reveals a Non-G<sub>q<\/sub> Signaling Mode: Implications for Diversification of Intracellular Signal Transduction Mol Pharmacol","volume":"75","author":"AJ Copik","year":"2009"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2011.05.020","article-title":"Caveats and limitations of plate reader-based high-throughput kinetic measurements of intracellular calcium levels","volume":"255","author":"HJ Heusinkveld","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105159","article-title":"Allosteric Modulation of G Protein\u2013Coupled Receptors","volume":"47","author":"LT May","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-0773.1997.tb00396.x","article-title":"An affinity-modulating site on neuronal monoamine transport proteins","volume":"80","author":"P Plenge","year":"1997","journal-title":"Pharmacol Toxicol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/jpet.106.116764","article-title":"Pharmacological characterization of the nociceptin\/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrah ydro-5H-benzocyclohepten-5-ol]: in vitro studies","volume":"321","author":"B Spagnolo","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1021\/jm900743c","article-title":"Perspectives of p-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials","volume":"53","author":"NA Colabufo","year":"2010","journal-title":"J Med Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1472-8206.2009.00724.x","article-title":"P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone","volume":"23","author":"M Kanaan","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"KM Mahar Doan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref40","first-page":"27","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"P Artursson","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1568026013395010","article-title":"Assessing the absorption of new pharmaceuticals","volume":"1","author":"IJ Hidalgo","year":"2001","journal-title":"Curr Top Med Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.bmcl.2009.08.068","article-title":"Structure-activity relationship study on \u03b1<sub>1<\/sub> adrenergic receptor antagonists from beer","volume":"19","author":"T Wakimoto","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1074\/jbc.M112.430785","article-title":"Conopeptide \u03c1-TIA defines a new allosteric site on the extracellular surface of the \u03b1<sub>1B<\/sub>-adrenoceptor","volume":"288","author":"L Ragnarsson","year":"2013","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0022-3565(24)35223-1","article-title":"Binding, partial agonism, and potentiation of \u03b1<sub>1<\/sub>-adrenergic receptor function by benzodiazepines: a potential site of allosteric modulation","volume":"291","author":"DJ Waugh","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bcp.2006.09.010","article-title":"Structure-function of \u03b1<sub>1<\/sub>-adrenergic receptors","volume":"73","author":"DM Perez","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1124\/mol.57.3.436","article-title":"Allosteric interactions between the antagonist prazosin and amiloride analogs at the human \u03b1<sub>1A<\/sub>-adrenergic receptor","volume":"57","author":"RA Leppik","year":"2000","journal-title":"Mol Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/mol.110.067454","article-title":"Quantification of functional selectivity at the human \u03b1<sub>1A<\/sub>-adrenoceptor","volume":"79","author":"BA Evans","year":"2011","journal-title":"Mol Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0899-9007(00)00415-9","article-title":"Norepinephrine and the control of food intake","volume":"16","author":"PJ Wellman","year":"2000","journal-title":"Nutrition"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neuropharm.2011.05.030","article-title":"Noradrenergic regulation of itch transmission in the spinal cord mediated by \u03b1-adrenoceptors","volume":"61","author":"Y Gotoh","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0091-3057(88)90316-4","article-title":"Alpha noradrenergic agonists promote catalepsy in the mouse","volume":"31","author":"NC Sukul","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional \u03b1<sub>1<\/sub>-adrenoceptor","volume":"67","author":"JR Docherty","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/0024-3205(87)90702-8","article-title":"Evidence that reciprocal hindlimb scratching elicited in mice by intrathecal administration of muscarinic agonists is mediated through M<sub>1<\/sub> type receptors","volume":"41","author":"RB Raffa","year":"1987","journal-title":"Life Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0091-3057(87)90126-2","article-title":"Pilocarpine-induced reciprocal hindlimb scratching in mice","volume":"26","author":"RW Scott","year":"1987","journal-title":"Pharmacol, Biochem Behav"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.108.145219","article-title":"Selectivity of agonists for the active state of M<sub>1<\/sub> to M<sub>4<\/sub> muscarinic receptor subtypes","volume":"328","author":"KW Figueroa","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human \u03ba-opioid receptor in complex with JDTic","volume":"485","author":"H Wu","year":"2012","journal-title":"Nature"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature11085","article-title":"Structure of the nociceptin\/orphanin FQ receptor in complex with a peptide mimetic","volume":"485","author":"AA Thompson","year":"2012","journal-title":"Nature"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.110.002667","article-title":"Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes","volume":"62","author":"NJ Smith","year":"2010","journal-title":"Pharmacol Rev"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneumeth.2007.12.004","article-title":"Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity","volume":"169","author":"S Jorgensen","year":"2008","journal-title":"J Neurosci Methods"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"19402","DOI":"10.1074\/jbc.M109.024711","article-title":"Structural determinants of G-protein \u03b1 subunit selectivity by regulator of G-protein signaling 2 (RGS2)","volume":"284","author":"AJ Kimple","year":"2009","journal-title":"J Biol Chem"},{"key":"ref60","unstructured":"National Institute of Mental Health (2008) NIMH Psychoactive Drug Screening Program Assay Protocol Book. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/pdsp.med.unc.edu\/UNC-CH%20Protocol%20Book.pdf\" xlink:type=\"simple\">http:\/\/pdsp.med.unc.edu\/UNC-CH%20Protocol%20Book.pdf<\/ext-link>. Archived at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.webcitation.org\/6AfPc6HyI\" xlink:type=\"simple\">http:\/\/www.webcitation.org\/6AfPc6HyI<\/ext-link>. Accessed 2013 July 2."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0070701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T13:52:51Z","timestamp":1746021171000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0070701"}},"subtitle":[],"editor":[{"given":"James","family":"Porter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0070701","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]}}}